Cortexyme (CRTX) Income Statement

Click line-items for a historical chart and %

Net revenues	53.7M
Cost of product sales (exclusive of amortization of product rights)	12.64M
Selling, general and administrative	16.37M
Royalties
Research and development	594K
Amortization of product rights
Total costs and expenses	37.66M
Income (loss) from operations	16.04M
Interest expense, net	-1.68M
Total other expenses	-1.79M
Income (loss) before income taxes	14.25M
(Provision for) benefit from income taxes	-4.68M
Net income (loss)	9.58M
Net income (loss) per share, basic	0.36
Net income (loss) per share, diluted	0.31
Weighted-average common shares, basic	26.52M
Weighted-average common shares, diluted	31.5M

Entities mentioned with CRTX

View All Entities